At the forefront of therapies for rare and orphan diseasesTM
HOME CONTACT US         
Share
about us| programs| science & technology | patient advocacy | clinical studies | investors | collaborations | news & events
 
Investors
 



Home >> Investor Relations >> Corporate Governance >> Insider Transactions

Insider Transactions

Date Name Title Type Sorted Ascending Shares Traded Price Range
Jul 30, 2008 bloch stephen m Director Automatic Sell 4,700 15.19
Jul 31, 2008 bloch stephen m Director Automatic Sell 10,000 15.47 - 15465.00
Aug 1, 2008 bloch stephen m Director Automatic Sell 3,700 15.45
Aug 5, 2008 bloch stephen m Director Automatic Sell 3,000 15.55
Aug 6, 2008 bloch stephen m Director Automatic Sell 4,879 15.60 - 16.77
Aug 7, 2008 bloch stephen m Director Automatic Sell 4,200 16.58
Aug 8, 2008 bloch stephen m Director Automatic Sell 3,000 16.70
Aug 11, 2008 bloch stephen m Director Automatic Sell 3,500 16.26 - 17.38
Aug 12, 2008 bloch stephen m Director Automatic Sell 7,620 16.65 - 17.29
Aug 4, 2008 bloch stephen m Director Automatic Sell 4,500 15.23
Aug 13, 2008 bloch stephen m Director Automatic Sell 5,700 17.57
Aug 14, 2008 bloch stephen m Director Automatic Sell 10,066 17.03
Aug 15, 2008 bloch stephen m Director Automatic Sell 3,000 16.46
Aug 18, 2008 bloch stephen m Director Automatic Sell 3,000 14.82 - 15.46
Aug 20, 2008 bloch stephen m Director Automatic Sell 3,000 13.72
Aug 21, 2008 bloch stephen m Director Automatic Sell 3,000 13.57
Aug 22, 2008 bloch stephen m Director Automatic Sell 3,000 13.52
Aug 25, 2008 bloch stephen m Director Automatic Sell 3,000 13.67
Aug 26, 2008 bloch stephen m Director Automatic Sell 4,200 13.64
Aug 19, 2008 bloch stephen m Director Automatic Sell 3,000 13.56
Showing 41-60 of 392 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Amicus Therapeutics, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.
Copyright © 2012 Amicus Therapeutics, Inc. All rights reserved.   Terms of Use | Privacy Policy